What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Angela Dispenzieri spends much of her time researching Internal medicine, Multiple myeloma, Gastroenterology, Surgery and Pathology.
Her research links Immunology with Internal medicine.
Her Multiple myeloma study combines topics in areas such as Monoclonal gammopathy of undetermined significance and Dexamethasone.
Angela Dispenzieri has included themes like Antibody, Myeloma protein, Hazard ratio, Survival analysis and Risk factor in her Gastroenterology study.
Her work is dedicated to discovering how Surgery, Clinical trial are connected with MEDLINE and other disciplines.
Her Transplantation study combines topics from a wide range of disciplines, such as Stem cell and Oncology.
Her most cited work include:
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. (1954 citations)
- Improved survival in multiple myeloma and the impact of novel therapies (1773 citations)
- Review of 1027 Patients With Newly Diagnosed Multiple Myeloma (1596 citations)
What are the main themes of her work throughout her whole career to date?
Angela Dispenzieri focuses on Internal medicine, Multiple myeloma, Surgery, Amyloidosis and Gastroenterology.
Angela Dispenzieri works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Clinical trial.
Her work carried out in the field of Multiple myeloma brings together such families of science as Monoclonal gammopathy of undetermined significance and Bone marrow, Pathology.
As part of her studies on Surgery, Angela Dispenzieri frequently links adjacent subjects like Cohort.
She focuses mostly in the field of Amyloidosis, narrowing it down to matters related to Immunoglobulin light chain and, in some cases, Molecular biology.
Her Gastroenterology research includes themes of Hazard ratio, Survival rate, Primary systemic amyloidosis, Myeloma protein and Survival analysis.
She most often published in these fields:
- Internal medicine (61.31%)
- Multiple myeloma (46.56%)
- Surgery (25.98%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (61.31%)
- Multiple myeloma (46.56%)
- Amyloidosis (23.53%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Amyloidosis, Oncology and AL amyloidosis.
Many of her studies on Internal medicine apply to Gastroenterology as well.
Her Gastroenterology study integrates concerns from other disciplines, such as Stage, Monoclonal gammopathy of undetermined significance, Progression-free survival and Survival rate.
Her research in Multiple myeloma intersects with topics in Newly diagnosed, Survival analysis and Bone marrow.
Her Amyloidosis study which covers Immunoglobulin light chain that intersects with Monoclonal.
The AL amyloidosis study combines topics in areas such as Hazard ratio, Retrospective cohort study, Melphalan and Very Good Partial Response.
Between 2017 and 2021, her most popular works were:
- Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. (195 citations)
- Systemic immunoglobulin light chain amyloidosis. (164 citations)
- Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis (156 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Her scientific interests lie mostly in Internal medicine, Amyloidosis, Multiple myeloma, AL amyloidosis and Gastroenterology.
In her study, which falls under the umbrella issue of Internal medicine, MEDLINE is strongly linked to Oncology.
Her work deals with themes such as Immunoglobulin light chain, Amyloid, Hematologic Response and Cardiology, which intersect with Amyloidosis.
Her Multiple myeloma research incorporates themes from Newly diagnosed, Anemia, Hazard ratio, Confidence interval and Survival analysis.
Her study looks at the intersection of Hazard ratio and topics like Surgery with Thalidomide.
Her study on Gastroenterology also encompasses disciplines like
- Bone marrow that intertwine with fields like Myeloma protein,
- Waldenstrom macroglobulinemia together with Complication and Monoclonal gammopathy of undetermined significance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
